Striatal dopamine transporter binding in adults with 22q11.2 copy number variants: a SPECT study
Brain Communications · 31.10.2026 · 8 (6)
DOI: 10.1093/braincomms/fcag395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 19.10.2026. Verfasst von Jeltje C C Spapens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health and Neuroscience Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Reference Network on Rare Congenital Malformations, Rare Intellectual Disability ERN-ITHACA, ERN-ITHACA.
Abstract (Originalsprache)
Copy number variants at the 22q11.2 chromosomal locus, hemizygous 22q11.2 deletions or duplications, are associated with a broad spectrum of neuropsychiatric and other medical conditions. Individuals with a 22q11.2 deletion are at increased risk for developing early-onset Parkinson’s disease. The catechol-O-methyltransferase gene at 22q11.2 is involved in dopamine metabolism. While previous studies have examined several aspects of dopamine function in individuals with 22q11.2 copy number variants, striatal dopamine transporter availability, a regulator of synaptic dopamine, has not yet been systematically investigated. Therefore, dopamine transporter availability was quantified in nine adults with a 22q11.2 deletion, nine with a 22q11.2 duplication and eight controls using a brain-dedicated single-photon emission computed tomography (SPECT) system. Specific striatal binding ratios were calculated with the occipital lobe as the reference region. Permutation analysis of covariance controlling for age and sex showed significantly higher striatal dopamine transporter availability in adults with 22q11.2 deletions compared with those with duplications (P = 0.026, η2p = 0.30). No significant differences were observed between adults with 22q11.2 copy number variants and controls. These findings suggest distinct nigrostriatal dopaminergic profiles associated with 22q11.2 copy number variant status, which may play a role in shaping frequently occurring neurological and psychiatric phenotypes in these individuals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mental Health and Neuroscience Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands.
- Institute of Education and Child Studies, Leiden University, 2333 AK Leiden, The Netherlands.
- Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Advisium, 's Heeren Loo Zorggroep, 3818 LA, Amersfoort, The Netherlands.
- The Dalglish Family 22q Clinic, University Health Network, Toronto, Ontario M5G 2C4, Canada.
ORCID-Profile: Jeltje C C Spapens
Förderung
- European Reference Network on Rare Congenital Malformations
- Rare Intellectual Disability ERN-ITHACA
- ERN-ITHACA
- European Union
Zitieren
APA
Spapens, J. C. C., van Hooijdonk, C. F., Schalbroeck, R., Sylvester, A. L., Boot, E., van Amelsvoort, T. A. M. J., Vingerhoets, C., & Booij, J. (2026). Striatal dopamine transporter binding in adults with 22q11.2 copy number variants: a SPECT study. Brain Communications, 8(6). https://doi.org/10.1093/braincomms/fcag395
Vancouver
Spapens JCC, van Hooijdonk CF, Schalbroeck R, Sylvester AL, Boot E, van Amelsvoort TAMJ, et al. Striatal dopamine transporter binding in adults with 22q11.2 copy number variants: a SPECT study. Brain Communications. 2026;8(6). doi:10.1093/braincomms/fcag395
BibTeX
@article{Spapens2026,
author = {Spapens, Jeltje C C and van Hooijdonk, Carmen F and Schalbroeck, Rik and Sylvester, Amy L and Boot, Erik and van Amelsvoort, Thérèse A M J and Vingerhoets, Claudia and Booij, Jan},
title = {Striatal dopamine transporter binding in adults with 22q11.2 copy number variants: a SPECT study},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/braincomms/fcag395}
}
EUVIMED